Clinical trial
A Validation Study of the Gen-Probe APTIMA Combo2 (AC2) for Detecting Chlamydia Trachomatis and Neisseria Gonorrhoeae in Rectal Samples.
NCT00827697 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Validation Study of the Gen-Probe APTIMA Combo2 (AC2) for Detecting Chlamydia Trachomatis and Neisseria Gonorrhoeae in Rectal Samples.
- Lead sponsor
- University of Pittsburgh
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- March 31, 2010
- Enrollment
- 399 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
chlamydia, gonorrhea